electronRx, a digital medicine and biomarker company driving healthcare through pulmonary innovation, has announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical device standards, at CES 2025 from 7–10th January.
The global pharmaceutical industry is facing unprecedented supply chain challenges in the current climate of geopolitical uncertainty. Marco Gorgas, chief technical officer, Adragos Pharma explains.
Neuraxpharm Group (Neuraxpharm) and Pharmathen have announced a strategic alliance to co-develop new long-acting injectable therapies within the psychiatry field under Pharmathen’s long-acting therapeutic technologies (LATT) program.
NEC Bio Therapeutics presents 24-week promising interim results from an ongoing Phase 1 basket clinical trial of an orally administered cancer vaccine, NECVAX-NEO1.
Portescap’s business development manager for medical applications, Dave Beckstoffer, explains how drive systems for wearable and automatic drug delivery devices are central to the patient outcome.
Henny Zijlstra, chief commercial officer at Adragos Pharma shares how the era of change in the European CDMO landscape has brought in a greater focus on agility and customer centricity.
Astoriom has developed a new cryogenic storage suite at its Tramore facility, bringing unmatched capabilities for biological sample storage to Ireland.
